Immune Control
Latest round
- Series A
Last raised
- Jul 2005
Total raised
- $11M
Investors
- 5
About Immune Control
Immune Control, Inc. engages in development of drugs to stop undesirable proliferation of immune cells.
Who invested in Immune Control
5 investors across 1 round
See all investors in Immune Control
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 14, 2005
Amount
$11M
Investors
Questions about Immune Control
Who invested in Immune Control?
Immune Control has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Immune Control raised?
Immune Control has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Immune Control last raise money?
Immune Control's most recent round on record is a Series A, in Jul 2005.
What does Immune Control do?
Immune Control is a pharmaceuticals company.
Where is Immune Control headquartered?
Immune Control is headquartered in US.
Which VCs invest in companies like Immune Control?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Immune Control's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Immune Control? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.